As of March 2025 BioMarin Pharmaceutical has a market cap of A$21.76 Billion. This makes BioMarin Pharmaceutical the world's 1330th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Mar 25th, 2025 the market cap of BioMarin Pharmaceutical was reported to be: